Gentag, Inc. and The CORE Institute to Develop and Market Diagnostic Skin Patches

Published: Aug 17, 2007

Gentag, Inc. and The CORE Institute® in the USA have announced a joint collaborative effort to develop and market RFID diagnostic Skin Patches for Medical Applications in Orthopedics. The aim of the joint program is to facilitate post surgery monitoring applications by physicians and patients using RFID enabled cell phones under Gentag, Altivera and CORE patents. Physicians will monitor the status of damaged tissues using temperature, pressure, and other sensors. Additionally, patients will be able to self-monitor their recovery from the comfort of their own homes. The technology platform uses RFID enabled cell phones, PDAs or wireless laptops that allow remote monitoring by physicians and hospitals, particularly during the critical first 24 hours post injury or surgery.

Back to news